MoneyWorks4Me

Alivus Life Sciences informs about disclosure

20 Oct 2025 Evaluate
Pursuant to regulation 30(2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR Regulations) read with clause 20 of Para A of Part A of Schedule III of the LODR Regulations, Alivus Life Sciences has informed that the details of Notice/Order received by the Company from Office of The Gujarat Pollution Control Board (‘GPCB’) is enclosed as Annexure A.

The above information is a part of company’s filings submitted to BSE.  


Peers
Company Name CMP
Sun Pharma. Inds. 1842.95
Dr. Reddys Labs. 1218.75
Cipla 1387.85
Lupin 2063.85
Zydus Lifesciences 1222.50
View more..